Back To TOP

Genentech® Access to Care Foundation (GATCF)

GATCF helps eligible patients who meet specific insurance, financial and medical criteria receive their Genentech medicines free of charge.

Genentech has changed the eligibility criteria for patients who receive free medicine from GATCF. GATCF now considers certain patients without coverage for Genentech medicines and underinsured patients whose out-of-pocket costs for their Genentech medicines account for ≥10% of their annual household adjusted gross income (AGI) for program eligibility. Certain financial and medical criteria must also be met.

 


 

Is my patient eligible?

 

GATCF

 

Download this PDF file to view more information on eligibility criteria.

 


 

How do I get my patient started?

 

  1. Complete and submit enrollment forms and submit them to Genentech Access Solutions:
    • Statement of Medical Necessity (SMN)
    • Patient Authorization and Notice of Release of Information (PAN)
  2. Complete and submit additional forms as appropriate:
    • Insurance Attestation

      - For uninsured patients only

      - Serves as proof that the patient's insurance will not cover the prescribed Genentech therapy

    • Confirmation of Infusion or Injection

      - For office-administered products only

      - Completed after each infusion or injection

 

These forms can be submitted online via My Patient Solutions or downloaded from our Forms and Documents Center.

When completing the SMN, be sure to complete all sections of the form.

 

 

Only the information requested on these forms is required. Providing additional documents or information will delay processing.

 

Once we receive your patient’s information, Genentech Rheumatology Access Solutions will contact the patient within 24 hours with further instructions. This may include verifying financial eligibility.

 


 

Additional GATCF program details:

  • Patients are eligible for free medicine for 1 year; patients must reapply annually
  • Patient assistance support may be given before treatment or up to 1 year post-treatment
  • GATCF assists with the cost of ACTEMRA only, not the administration costs